LEXINGTON, Massachusetts & SYDNEY, Australia – 28 October 2014 – GI Dynamics, Inc. (ASX: GID) will hold a conference call to discuss the company’s financial results for the third quarter and six months ended 30 September 2014, and its business outlook. Michael D. Dale, president and chief executive officer, will host the call with Robert Crane, chief financial officer.
The company will file its Appendix 4C with the ASX on Friday, 31 October 2014 (AEST). The briefing call to discuss financial results and business updates will be held at 5 p.m. U.S. EST on Tuesday, 4 November 2014 (9 a.m. AEST on Wednesday, 5 November 2014).
Accessing the Briefing Call via Webcast:
Accessing the Briefing Call via Telephone:
For those preferring to listen by telephone, please dial in five minutes prior to the start of the call and provide the passcode 38279268. Regional dial-in numbers are as follows:
- United States callers please dial toll-free 1 (888) 771-4371
- Australia callers please dial toll-free 1 (800) 507-265
- International callers please dial 1 (847) 585-4405
The webcast will be archived for 30 days following the call on the GI Dynamics website at investor.gidynamics.com.
About GI Dynamics
GI Dynamics, Inc. (ASX: GID) is the developer of EndoBarrier®, the first endoscopically-delivered device therapy approved for the treatment of type 2 diabetes and/or obesity. EndoBarrier is approved and commercially available in multiple countries outside the U.S. EndoBarrier is not approved for sale in the U.S. and is limited by federal law to investigational use only in the United States. GI Dynamics is conducting a pivotal clinical trial of EndoBarrier in the U.S. for the treatment of patients who have uncontrolled type 2 diabetes and are obese. Founded in 2003, GI Dynamics is headquartered in Lexington, Massachusetts. For more information, please visit www.gidynamics.com.
GI Dynamics, Inc.
Robert Crane, Chief Financial Officer
David Allen or John Granger, Hawkesbury Partners Pty Limited
+61 2 9325 9046
Dan Budwick, Pure Communications Inc.
Angela Ceberano, Flourish PR
+61 3 9092 8445